According to a new market research report published by Global Market Estimates, the Global Inactivated Vaccine Market is projected to grow at a CAGR value of 10.5% from 2022 to 2027.

Growing health consciousness and government efforts to support vaccination, technological developments and infrastructure upgrades in the healthcare system, increased emphasis on research studies, and cooperation among various top research facilities in the domain to find a new methodology to enhance inactivated vaccines are all contributing to the market growth.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Inactivated Vaccine Market - Forecast to 2027" https://www.globalmarketestimates.com/market-report/inactivated-vaccine-market-3754

 Key Market Insights

·         The viral vaccine segment is expected to be the fastest-growing segment in the Inactivated Vaccine market from 2022 to 2027 as per the vaccine type outlook

·         The solvent detergent method segment is expected to be the fastest-growing segment in the Inactivated Vaccine market from 2022 to 2027 as per the method of inactivation outlook

·          Based on route of administration, the subcutaneous segment is expected to be the fastest-growing segment in the Inactivated Vaccine market from 2022 to 2027

·         North America (the United States, Canada, and Mexico) will have a dominant share in the Global Inactivated Vaccine market from 2022 to 2027

·         GlaxoSmithKline plc, Merck & Co., Inc, CSL Limited, Sanofi, Valneva SE, Bharat Biotech, Pfizer Inc., Bavarian Nordic, Inovio Pharmaceuticals, Inc., Novavax, Inc., Serum Institute of India Pvt.Ltd., Daiichi Sankyo Company, Limited, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, among others are key players in the inactivated vaccines market.
Vaccine Type Outlook (Revenue, USD Billion, 2022 - 2027)

·         Viral Vaccine

·         Bacterial Vaccine 

Method of Inactivation Outlook (Revenue, USD Billion, 2022 - 2027)

·         Detergent Method

·         Radiation Method

·         pH Concentration

·         Heat Inactivation

·         Others

Route of Administration Outlook (Revenue, USD Billion, 2022 - 2027)

·         Oral

·         Subcutaneous

·         Intravenous

·         Others

Regional Outlook (Revenue, USD Billion, 2022-2027)

North America                                                                                 

• The U.S.
• Canada
• Mexico

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC

Central & South America

• Brazil
• Argentina
• Rest of CSA

Middle East & Africa

• Saudi Arabia
• UAE
• Rest of MEA

 

Contact: Yash Jain

Email address: yash.jain@globalmarketestimates.com

Phone Number: +16026667238